Clinical Trials Logo

Clinical Trial Summary

Background: An electroencephalogram (EEG) measures the brain s electrical activity. EEG shows that the louder the sound needed to wake a person, the deeper the person s sleep. Researchers are using functional magnetic resonance imaging (fMRI) to study people during sleep so they can view brain activity in 3D. But they still need to correlate fMRI with sound thresholds, like the EEG. Objective: To measure brain activity during sleep using fMRI and EEG. Eligibility: Healthy people ages 18 34 who can sleep on their back for several hours. Design: Participants will be screened online about their sleep and general health. At a screening visit, participants will have: Physical exam Hearing exam MRI scan. A strong magnetic field and radio waves take pictures of the brain. Participants will lie down on a bed that slides into the scanner, which is shaped like a cylinder. Participants will wear an actigraph on their wrist that records their motor activity. Participants will follow a 2-week routine. This includes regular in-to-bed and out-of-bed times and limits on alcohol, caffeine, and nicotine. During the overnight visits, participants will have: Female subjects will have a urine pregnancy test. fMRI. A coil will be placed over the head. Participants will do tasks shown on a computer screen inside the scanner. EEG. Small electrodes on the scalp will record brain waves while sleeping or doing a task in the scanner. Participants will be asked to try to sleep while researchers collect fMRI and EEG data. Participants eyes will be monitored with a video camera. Headphones will deliver sounds to wake them up throughout the night.


Clinical Trial Description

Objective Electroencephalography is generally considered the gold standard for defining sleep, but, in fact, sleep is a behavior and is defined by widely accepted behavioral characteristics like auditory arousal threshold. Electroencephalography merely became a surrogate for the behavioral definition when, in the first electroencephalographic sleep studies, researchers discovered a strong correlation between electroencephalographic slow waves and auditory arousal thresholds. With the advent of functional magnetic resonance imaging, one would expect the first sleep studies that used this new measure would have been designed to correlate it with auditory arousal threshold. However, these studies have never been conducted. This protocol will fill this gap in the literature. We hypothesize that undiscovered patterns of brain activity or functional connectivity exist during sleep and that an approach that defines sleep behaviorally will expose these patterns. Study Population The subject group in this study will be young, healthy individuals with excellent sleep health. Choosing this subject group will maximize the probability that subjects will sleep during all-night functional magnetic resonance imaging. Our target number of completers was 12 for the pilot study and is 43 for the main study. Design After a one-week home-monitoring period that includes a regular in-to-bed and out-of-bed time, subjects will undergo two all-night functional magnetic resonance imaging sleep studies separated by a one-week washout period with continued home monitoring. The first night will serve as an adaptation night, which is known to reduce the sleep alterations that accompany sleeping in a laboratory environment. We will measure sleep depth behaviorally by arousing subjects with auditory stimuli that progressively increase in intensity. This procedure will be performed approximately eight times per night. The timing of the arousals will be distributed randomly across the night. Data Generated The data generated will be auditory arousal thresholds and the preceding brain activity and functional connectivity derived from functional magnetic resonance imaging. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02629107
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact Susan Guttman
Phone (301) 451-9912
Email fultons@mail.nih.gov
Status Recruiting
Phase
Start date January 14, 2016
Completion date December 31, 2027

See also
  Status Clinical Trial Phase
Recruiting NCT00109174 - MRS Measurement of Glutamate and GABA Metabolism in Brain N/A
Not yet recruiting NCT06050603 - MRI Guided Closed-loop TMS-EEG N/A
Recruiting NCT03288220 - Influence of Brain Oscillation-Dependent TMS on Motor Function
Terminated NCT01123499 - Collection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal Volunteers
Completed NCT03324646 - Evaluation of a Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)
Recruiting NCT05398783 - A Natural History Study of Metabolic Sizing in Health and Disease
Completed NCT02911129 - Effects of Prism Adaption and rTMS on Brain Connectivity and Visual Representation
Recruiting NCT01324206 - Development of 3T Magnetic Resonance Research Methods for NIA Studies
Completed NCT01593709 - Volunteer Screening for Vaccine and Antivirals Clinical Trials
Completed NCT01730144 - Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults
Recruiting NCT03258580 - Sociocultural & Biobehavioral Influences on Pain Expression and Assessment N/A
Not yet recruiting NCT05666739 - NIEHS Repository of Stored Biological Samples for Future Use
Completed NCT02669225 - Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People Early Phase 1
Recruiting NCT04950309 - Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array N/A
Completed NCT00267904 - Reference Values for Plasma Catechols Phase 1
Recruiting NCT05707806 - Development and Validation of Learning and Decision-Making Tasks
Recruiting NCT03407066 - Perception, Sensation, Cognition and Action in Humans
Recruiting NCT02707042 - Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study) Phase 1
Completed NCT00860886 - Premenopausal Hormone Concentrations in a Population of Women at Very Low Risk of Breast Cancer
Completed NCT02193425 - Reliability of the Human Brain Connectome Early Phase 1